That may be true, but I don’t recall myself. Then again, the results still aren’t so hot.

As for philanthropy, I guess a lot of people count themselves as idealists, and then many also believe corporate America should donate to whatever they believe is a worthy cause, or whatever.

Yesterday, I posted an item in which I suggested PhRMA create a foundation that would fund, with no strings attached, research into drugs that big pharma isn’t touching. I thought of that after reading the WSJ piece about the researcher who had to solicit his own trial patients to keep the wheels turning.

You’re right - people want affordable meds first. Then maybe a little philanthropy to make nice. Of course, it should be sincere, too.

Thanks for stopping by again,

ed

Although I don’t have the data at hand, I think this is actually an improvement over the past few years. The industry was negative for the past 3 or 4 years. As for the philanthropy side, I am convinced that IPSOS is wrong in its conclusion that raising awareness of the philanthropy will make a difference. There’s no indication that consumers want anything more than getting their meds for less money.